(Q53001161)

English

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle contr

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/9115000

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle contr (English)

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/9115000

author name string

J Endrikat

1

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/9115000

U Müller

2

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/9115000

B Düsterberg

3

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/9115000

publication date

1 March 1997

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/9115000

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/9115000

55

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/9115000

3

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/9115000

131-137

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/9115000

Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900025-5

7 January 2021

A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900025-5

7 January 2021

A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900025-5

7 January 2021

New progestogens in oral contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900025-5

7 January 2021

Clinical experience with a modern low-dose gestodene-containing oral contraceptive in adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900025-5

7 January 2021

Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900025-5

7 January 2021

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle co

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2897%2900025-5

7 January 2021

Identifiers

10.1016/S0010-7824(97)00025-5

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/9115000

1 reference

Europe PubMed Central

10 May 2018

http://europepmc.org/abstract/MED/9115000

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53001161&oldid=1372918609"